Finepoint Capital LP Incresed Positions in Q3 2024

Finepoint Capital LP

  • $963 Million
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
TVTX
Travere Therapeutics, Inc.

Healthcare
5.54K
+ 0.31%
$7.89 - $15.21 $43.7K - $84.2K
1.78M $24.9M
ARGX
Argenx Se

Healthcare
400
+ 0.74%
$434.22 - $551.9 $174K - $221K
54.4K $29.5M
RVMD
Revolution Medicines, Inc.

Healthcare
2.5K
+ 0.34%
$36.92 - $47.94 $92.2K - $120K
732K $33.2M
GLPG
Galapagos Nv

Healthcare
15K
+ 2.76%
$24.2 - $30.67 $363K - $460K
558K $16.1M
ASND
Ascendis Pharma A/S

Healthcare
800
+ 0.42%
$113.0 - $153.43 $90.4K - $123K
190K $28.4M
RLAY
Relay Therapeutics, Inc.

Healthcare
20.8K
+ 1.3%
$6.23 - $9.51 $130K - $198K
1.63M $11.5M
SWTX
Spring Works Therapeutics, Inc.

Healthcare
12.5K
+ 1.96%
$32.04 - $42.76 $401K - $535K
651K $20.9M
SRPT
Sarepta Therapeutics, Inc.

Healthcare
700
+ 0.53%
$124.33 - $156.75 $87K - $110K
134K $16.7M
Activity Summary
Buys All Purchases 10 New Holdings 2 Increased Positions 8 Sells All Sells 0 Reductions 0 Sold out 0 Options Calls 0 Puts 2
Track This Portfolio

Track Finepoint Capital LP Portfolio

Follow Finepoint Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Finepoint Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email